213 related articles for article (PubMed ID: 19033009)
1. Disparity in drug-eluting stent utilization by insurance type.
Kao J; Vicuna R; House JA; Rumsfeld JS; Ting HH; Spertus JA
Am Heart J; 2008 Dec; 156(6):1133-40. PubMed ID: 19033009
[TBL] [Abstract][Full Text] [Related]
2. Insurance type influences the use of drug-eluting stents.
Gaglia MA; Torguson R; Xue Z; Gonzalez MA; Collins SD; Ben-Dor I; Syed AI; Maluenda G; Delhaye C; Hanna N; Wakabayashi K; Kaneshige K; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
JACC Cardiovasc Interv; 2010 Jul; 3(7):773-9. PubMed ID: 20650440
[TBL] [Abstract][Full Text] [Related]
3. African-American patients are less likely to receive drug-eluting stents during percutaneous coronary intervention.
Gaglia MA; Shavelle DM; Tun H; Bhatt J; Mehra A; Matthews RV; Clavijo L
Cardiovasc Revasc Med; 2014 Jun; 15(4):214-8. PubMed ID: 24814420
[TBL] [Abstract][Full Text] [Related]
4. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
5. Morbidity and mortality of colorectal carcinoma surgery differs by insurance status.
Kelz RR; Gimotty PA; Polsky D; Norman S; Fraker D; DeMichele A
Cancer; 2004 Nov; 101(10):2187-94. PubMed ID: 15382089
[TBL] [Abstract][Full Text] [Related]
6. Health insurance status and hypertension monitoring and control in the United States.
Duru OK; Vargas RB; Kermah D; Pan D; Norris KC
Am J Hypertens; 2007 Apr; 20(4):348-53. PubMed ID: 17386339
[TBL] [Abstract][Full Text] [Related]
7. Treatment variation by insurance status for breast cancer patients.
Coburn N; Fulton J; Pearlman DN; Law C; DiPaolo B; Cady B
Breast J; 2008; 14(2):128-34. PubMed ID: 18315690
[TBL] [Abstract][Full Text] [Related]
8. Insurance status and the use of guideline therapy in the treatment of selected cancers.
Harlan LC; Greene AL; Clegg LX; Mooney M; Stevens JL; Brown ML
J Clin Oncol; 2005 Dec; 23(36):9079-88. PubMed ID: 16301598
[TBL] [Abstract][Full Text] [Related]
9. Insurance status and asthma-related health care utilization in patients with severe asthma.
Peters AT; Klemens JC; Haselkorn T; Weiss ST; Grammer LC; Lee JH; Chen H;
Ann Allergy Asthma Immunol; 2008 Apr; 100(4):301-7. PubMed ID: 18450113
[TBL] [Abstract][Full Text] [Related]
10. The impact of insurance instability on children's access, utilization, and satisfaction with health care.
Cassedy A; Fairbrother G; Newacheck PW
Ambul Pediatr; 2008; 8(5):321-8. PubMed ID: 18922506
[TBL] [Abstract][Full Text] [Related]
11. Minding the gap: a decomposition of emergency department use by Medicaid enrollees and the uninsured.
Mortensen K; Song PH
Med Care; 2008 Oct; 46(10):1099-107. PubMed ID: 18815532
[TBL] [Abstract][Full Text] [Related]
12. Insurance status and outcome after intracerebral hemorrhage: findings from Get With The Guidelines-stroke.
James ML; Grau-Sepulveda MV; Olson DM; Smith EE; Hernandez AF; Peterson ED; Schwamm LH; Bhatt DL; Fonarow GC
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):283-92. PubMed ID: 23537567
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic status and utilization of health care services in Canada and the United States: findings from a binational health survey.
Blackwell DL; Martinez ME; Gentleman JF; Sanmartin C; Berthelot JM
Med Care; 2009 Nov; 47(11):1136-46. PubMed ID: 19786920
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario.
Goeree R; Bowen JM; Blackhouse G; Lazzam C; Cohen E; Chiu M; Hopkins R; Tarride JE; Tu JV
Int J Technol Assess Health Care; 2009 Apr; 25(2):196-207. PubMed ID: 19331710
[TBL] [Abstract][Full Text] [Related]
15. Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowings.
Harjai KJ; Orshaw P; Boura J; Sporn D
Am J Cardiol; 2009 Jun; 103(11):1537-45. PubMed ID: 19463512
[TBL] [Abstract][Full Text] [Related]
16. Disparities in imaging utilization for acute ischemic stroke based on patient insurance status.
Brinjikji W; El-Sayed AM; Rabinstein AA; McDonald JS; Cloft HJ
AJR Am J Roentgenol; 2014 Aug; 203(2):372-6. PubMed ID: 25055273
[TBL] [Abstract][Full Text] [Related]
17. Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications.
Ko DT; Chiu M; Guo H; Austin PC; Goeree R; Cohen E; Labinaz M; Tu JV
J Am Coll Cardiol; 2009 May; 53(19):1773-82. PubMed ID: 19422984
[TBL] [Abstract][Full Text] [Related]
18. Selection of patients for drug-eluting stents based on insurance coverage: pay or don't play.
Krone RJ
JACC Cardiovasc Interv; 2010 Jul; 3(7):780-2. PubMed ID: 20650441
[No Abstract] [Full Text] [Related]
19. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
20. The impact of insurance status on outcomes after surgery for spinal metastases.
Dasenbrock HH; Wolinsky JP; Sciubba DM; Witham TF; Gokaslan ZL; Bydon A
Cancer; 2012 Oct; 118(19):4833-41. PubMed ID: 22294322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
